UNSPSC 51172153: Trospium

This classification denotes an antimuscarinic agent with the molecular formula C25H30NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T4Y8ORK057, chemically known as 6,10-ethano-5-azoniaspiro(4.5)decan-8-ol, chloride, benzilate but generally known as trospium, which bears US NIH Compound Identifier 107979. European Medicines Agency schedules Trospium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05000MIG.

UNSPSC 51172153 Trospium is a Commodity code that represents pharmaceutical products, but the recent state and local activity mapped to this code does not reflect pharmaceutical procurement. Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services—posted September 25, 2026 with proposals due July 23, 2026—is a services contract centered on testing administration, lab operations, and chain-of-custody management rather than the purchase or supply of trospium itself. The scope includes staffing two collection sites in Plano and McKinney, operation of an Interactive Voice Response notification system, immunoassay and confirmatory testing (LC/MS/MS or GC/MS), electronic reporting, and alternative matrices including oral fluid and hair testing. The county expects approximately 25,031 tests annually and requires lab certification from SAMHSA, TX DPS, or CAP. The successful vendor will provide all staffing, freight, delivery, and insurance on a per-test basis across three pricing models (screening only, confirmation after screening, or screening with automatic confirmation of positives), with no surcharges permitted and annual price redetermination capped at 3.0 percent based on medical Consumer Price Index increases. Evaluation weighs vendor understanding (30 points), firm qualifications (25 points), client references (15 points), cost (30 points), and optional Phase 2 demonstrations and interviews (up to 30 points). The contract is estimated at $600,000 over two years commencing September 1, 2026, with three optional one-year renewals not to exceed five years total.

This code shows minimal relevant recent activity. The single solicitation under the code appears to reflect a tagging mismatch—the actual work being procured is criminal-justice drug-testing services, not trospium pharmaceutical supply. No additional state or local opportunities under this code are present in the source. Procurement professionals evaluating whether this Commodity code merits pursuit should note that it does not currently represent active state and local buying of the pharmaceutical product itself.